The estimated Net Worth of Joel Mc Comb is at least $1.91 million dollars as of 15 February 2018. Joel Comb owns over 50,000 units of Avid Bioservices Inc stock worth over $1,253,000 and over the last 17 years Joel sold CDMOP stock worth over $653,000.
Sign up
Joel Comb CDMOP stock SEC Form 4 insiders trading
Joel has made over 5 trades of the Avid Bioservices Inc stock since 2009, according to the Form 4 filled with the SEC. Most recently Joel sold 50,000 units of CDMOP stock worth $326,500 on 19 September 2018.
The largest trade Joel's ever made was selling 50,000 units of Avid Bioservices Inc stock on 19 September 2018 worth over $326,500. On average, Joel trades about 17,220 units every 275 days since 2008. As of 15 February 2018 Joel still owns at least 50,000 units of Avid Bioservices Inc stock.
You can see the complete history of Joel Comb stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's Joel Comb's mailing address?
Joel's mailing address filed with the SEC is 9885 TOWNE CENTRE DRIVE, , SAN DIEGO, CA, 92121-1975.
Insiders trading at Avid Bioservices Inc
Over the last 7 years, insiders at Avid Bioservices Inc have traded over $326,500 worth of Avid Bioservices Inc stock and bought 164,445 units worth $426,401 . The most active insiders traders include Gregory Sargen, Mark R Bamforth et Richard B Hancock. On average, Avid Bioservices Inc executives and independent directors trade stock every 95 days with the average trade being worth of $895,669. The most recent stock trade was executed by Richard B Hancock on 10 September 2019, trading 10,000 units of CDMOP stock currently worth $50,900.
What does Avid Bioservices Inc's logo look like?
Complete history of Joel Comb stock trades at Illumina Inc, Avid Bioservices Inc et Avid Bioservices Inc
Avid Bioservices Inc executives and stock owners
Avid Bioservices Inc executives and other stock owners filed with the SEC include:
-
Mark Ziebell,
Vice President, General Counsel, Corporate Secretary -
Daniel Hart,
Chief Financial Officer -
Richard Hancock,
Director -
Catherine Mackey,
Independent Director -
Richard Richieri,
Chief Operations Officer -
Joseph Carleone,
Independent Non-Executive Chairman of the Board -
Gregory Sargen,
Independent Director -
Patrick Walsh,
Independent Director -
Mark Bamforth,
Independent Director -
Stephanie Diaz,
Investor Relations / Corporate Communications -
Timothy Compton,
Chief Commercial Officer -
Nicholas Green,
President, Chief Executive Officer, Director -
Roger J. Lias,
President & CEO -
Joel Mc Comb,
Director